HC Wainwright Reiterates “Buy” Rating for Core Scientific (NASDAQ:CORZ)

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They presently have a $25.00 price objective on the stock. HC Wainwright’s target price suggests a potential upside of 57.83% from the stock’s current price.

A number of other research firms have also commented on CORZ. Zacks Research raised shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of Core Scientific in a research report on Wednesday, January 21st. Citizens Jmp upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target for the company in a report on Thursday, December 18th. BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. Finally, Sanford C. Bernstein boosted their price objective on Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Core Scientific presently has an average rating of “Moderate Buy” and an average price target of $24.84.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $15.84 on Tuesday. The stock has a market capitalization of $4.99 billion, a P/E ratio of 13.54 and a beta of 6.87. The business has a 50-day moving average of $17.28 and a two-hundred day moving average of $16.96. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.69. The company had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. During the same period in the previous year, the business posted ($0.69) earnings per share. The firm’s revenue was down 16.0% on a year-over-year basis. As a group, research analysts expect that Core Scientific will post 0.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Core Scientific

A number of institutional investors have recently added to or reduced their stakes in the company. Allworth Financial LP raised its holdings in Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after acquiring an additional 950 shares in the last quarter. Larson Financial Group LLC increased its position in shares of Core Scientific by 936.7% during the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock valued at $27,000 after purchasing an additional 1,686 shares during the period. HHM Wealth Advisors LLC raised its stake in shares of Core Scientific by 96.5% in the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock valued at $33,000 after purchasing an additional 946 shares in the last quarter. Osaic Holdings Inc. raised its stake in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after purchasing an additional 1,066 shares in the last quarter. Finally, Danske Bank A S bought a new position in Core Scientific in the fourth quarter worth $36,000.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Multiple analyst upgrades/raises reinforce bullish expectations — Canaccord raised its target to $20 and kept a Buy rating, Needham upgraded to Buy with a $23 target, and HC Wainwright reaffirmed Buy at $25, signaling institutional conviction in the AI pivot and creating upside narrative for the stock. Canaccord Raise
• Positive Sentiment: Colocation (AI) revenue is accelerating — company reports show colocation revenue surged ~268% YoY, driven by contracts such as CoreWeave; that growth supports the strategic shift from Bitcoin mining toward higher-margin AI services. Colocation Revenue Surge
• Positive Sentiment: CoreWeave deal progressing ahead of schedule — management commentary and press pieces note the CoreWeave relationship is on track, supporting near-term colocation revenue visibility. CoreWeave Ahead of Schedule
• Positive Sentiment: Large call-option activity suggests speculative/bullish positioning — unusually high call volume (≈188,642 calls) indicates investors are placing leveraged bullish bets ahead of anticipated upside from the AI pivot.
• Neutral Sentiment: MarketBeat / analysis pieces argue a long-term, multi-billion backlog tied to AI colocation could unlock large upside, but these are thesis pieces rather than new company disclosures; useful for framing upside but dependent on execution. MarketBeat AI Thesis
• Neutral Sentiment: Short-interest entries in the feed show anomalous/zero values (likely reporting noise) and do not provide actionable short-seller signal at this time.
• Negative Sentiment: Top-line weakness and volatility in earnings — Q4 results showed a sharp revenue decline (reports cite ~38% YoY drop) and a revenue miss versus consensus, and management flagged negative adjusted EBITDA tied to the transition/expansion which pressured sentiment and drove intraday weakness after the release. Q4 Revenue Fall
• Negative Sentiment: Near-term sell-side caution and price action — media and market coverage noted a material stock pullback (one headline cited a ~14% drop after the pivot/earnings), reflecting investor concern about execution risk, cash burn for expansion, and balance-sheet pressure. Stock Drop After Pivot

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.